Clinical Trials Browser

Phase 2 × Uveal Melanoma × Axitinib × Clear all

NCT01533948 2018-05-09

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Phase 2 Terminated

25 enrolled 11 charts

Uveal Melanoma, Melanoma